» Articles » PMID: 18068491

The Aerosol Rabbit Model of TB Latency, Reactivation and Immune Reconstitution Inflammatory Syndrome

Abstract

The large reservoir of human latent tuberculosis (TB) contributes to the global success of the pathogen, Mycobacterium tuberculosis (Mtb). We sought to test whether aerosol infection of rabbits with Mtb H37Rv could model paucibacillary human latent TB. The lung burden of infection peaked at 5 weeks after aerosol infection followed by host containment of infection that was achieved in all rabbits. One-third of rabbits had at least one caseous granuloma with culturable bacilli at 36 weeks after infection suggesting persistent paucibacillary infection. Corticosteroid-induced immunosuppression initiated after disease containment resulted in reactivation of disease. Seventy-two percent of rabbits had culturable bacilli in the right upper lung lobe homogenates compared to none of the untreated controls. Discontinuation of dexamethasone led to predictable lymphoid recovery, with a proportion of rabbits developing multicentric large caseous granuloma. The development and severity of the immune reconstitution inflammatory syndrome (IRIS) was dependent on the antigen load at the time of immunosuppression and subsequent bacillary replication during corticosteroid-induced immunosuppression. Clinically, many aspects were similar to IRIS in severely immunosuppressed HIV-infected patients who have functional restoration of T cells in response to effective (highly active) antiretroviral therapy. This corticosteroid model is the only animal model of the IRIS. Further study of the rabbit model of TB latency, reactivation and IRIS may be important in understanding the immunopathogenesis of these poorly modeled states as well as for improved diagnostics for specific stages of disease.

Citing Articles

Understanding the development of tuberculous granulomas: insights into host protection and pathogenesis, a review in humans and animals.

Lyu J, Narum D, Baldwin S, Larsen S, Bai X, Griffith D Front Immunol. 2024; 15:1427559.

PMID: 39717773 PMC: 11663721. DOI: 10.3389/fimmu.2024.1427559.


Pulmonary tuberculosis epidemiology and genetics in Kazakhstan.

Yerezhepov D, Gabdulkayum A, Akhmetova A, Kozhamkulov U, Rakhimova S, Kairov U Front Public Health. 2024; 12:1340673.

PMID: 38706548 PMC: 11066200. DOI: 10.3389/fpubh.2024.1340673.


Animals in Respiratory Research.

Frohlich E Int J Mol Sci. 2024; 25(5).

PMID: 38474149 PMC: 10931704. DOI: 10.3390/ijms25052903.


Advances in protein subunit vaccines against tuberculosis.

Zhang Y, Xu J, Hu Z, Fan X Front Immunol. 2023; 14:1238586.

PMID: 37654500 PMC: 10465801. DOI: 10.3389/fimmu.2023.1238586.


Dormancy: How to Fight a Hidden Danger.

Salina E, Makarov V Microorganisms. 2022; 10(12).

PMID: 36557586 PMC: 9784227. DOI: 10.3390/microorganisms10122334.


References
1.
MCCUNE R, FELDMANN F, McDermott W . Microbial persistence. II. Characteristics of the sterile state of tubercle bacilli. J Exp Med. 1966; 123(3):469-86. PMC: 2138156. DOI: 10.1084/jem.123.3.469. View

2.
Tsai M, Chakravarty S, Zhu G, Xu J, Tanaka K, Koch C . Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension. Cell Microbiol. 2006; 8(2):218-32. DOI: 10.1111/j.1462-5822.2005.00612.x. View

3.
Ly L, Russell M, McMurray D . Microdissection of the cytokine milieu of pulmonary granulomas from tuberculous guinea pigs. Cell Microbiol. 2007; 9(5):1127-36. DOI: 10.1111/j.1462-5822.2006.00854.x. View

4.
Wendel K, Alwood K, Gachuhi R, Chaisson R, Bishai W, Sterling T . Paradoxical worsening of tuberculosis in HIV-infected persons. Chest. 2001; 120(1):193-7. DOI: 10.1378/chest.120.1.193. View

5.
Medlar E, Bernstein S, STEWARD D . A bacteriologic study of resected tuberculous lesions. Am Rev Tuberc. 1952; 66(1):36-43. DOI: 10.1164/art.1952.66.1.36. View